BSEAGM/EGM5h ago
Trident Texofab Ltd
Pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed details of voting results inclusive of remote e-voting and e-voting during AGM of the Company held on Wednesday, September 30, 2026 (commenced at 04:00 p.m. and concluded at 04:20 p.m.) through Video Conferencing (VC) / Other Audio Video Means (OAVM).
Trident Texofab Ltd has announced the voting results of its 18th Annual General Meeting (AGM) held on September 30, 2026. The meeting was conducted through Video Conferencing (VC) / Other Audio Video Means (OAVM). The voting results show that all resolutions were passed with high voting percentages. The company has also disclosed the details of the voting results, including the number of shareholders present in the meeting, the number of votes polled, and the percentage of votes in favor and against each resolution.
BSEInsider Trading / SASTRegulatory1d ago
Trident Texofab Ltd
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, we wish to inform you that the Trading Window for dealing in securities of the Company shall remain closed with effect from October 01, 2026 and shall be opened 48 (Forty-Eight) hours after the conclusion of the Meeting of the Board of Directors to be held for the purpose of declaration of Un-Audited Standalone Financial Results for the Quarter and half year ended September 30, 2026
Trident Texofab Ltd has announced the closure of its trading window from October 1, 2026, due to the upcoming declaration of un-audited standalone financial results for the quarter and half year ended September 30, 2026.
BSEAGM/EGM1d ago
Trident Texofab Ltd
Further to our letter dated September 08, 2026 and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), we enclose herewith summary of proceedings of 18th Annual General Meeting (AGM) of members of Trident Texofab Limited held on Wednesday, September 30, 2026 at 04:00 p.m., through Video Conferencing (VC) / Other Audio Video Means (OAVM) facility.
Trident Texofab Ltd held its 18th Annual General Meeting (AGM) on September 30, 2026, through video conferencing. The meeting was attended by directors and shareholders, and the necessary quorum was present. The Chairman, Chetan Jariwala, welcomed the attendees and delivered a speech on the company's performance and growth. The Company Secretary announced that the Notice convening the AGM and the Annual Report for the financial year ended March 31, 2026, were taken as read. The meeting also discussed the resolutions proposed in the AGM, including remote e-voting.
BSEInsider Trading / SASTPromoter Reclassif.24 Sept 2026
Trident Texofab Ltd
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hardik Desai Family Trust
Trident Texofab Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Hardik Desai Family Trust, indicating a change in promoter holding.
BSECompany UpdateRegulatory2 Sept 2026
Trident Texofab Ltd
The Company voluntarily requested withdrawal of its credit ratings from CRISIL Ratings Limited for the bank facilities availed from Axis Bank Limited, as the sanctioned credit limits are ....
Trident Texofab Ltd voluntarily requested withdrawal of its credit ratings from CRISIL Ratings Limited for the bank facilities availed from Axis Bank Limited, as the sanctioned credit limits are below the Bank's requirement for maintaining an external credit rating.
BSEInsider Trading / SASTPledge26 Aug 2026
Trident Texofab Ltd
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hardik Desai Family Trust
Hardik Desai Family Trust has made a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, acquiring 10,33,691 shares of Trident Texofab Ltd, representing 6.89% of the company's total share capital.
BSEInsider Trading / SASTPledge24 Aug 2026
Trident Texofab Ltd
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hardik Desai Family Trust
Hardik Desai Family Trust has acquired 5,000 shares of Trident Texofab Ltd, increasing its holding to 6.89% of the company's total voting capital.
BSEInsider Trading / SASTPromoter Reclassif.20 Aug 2026
Trident Texofab Ltd
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hardik Desai Family Trust
Hardik Desai Family Trust has made a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, indicating a change in the promoter group's shareholding in Trident Texofab Ltd. The trust acquired 39,425 shares carrying voting rights, increasing its holding to 6.79% of the total voting capital.
BSEInsider Trading / SASTPromoter Reclassif.14 Aug 2026
Trident Texofab Ltd
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hardik Desai Family Trust
Hardik Desai Family Trust has made a disclosure under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, indicating a change in promoter holding in Trident Texofab Ltd.
BSECompany UpdateResults12 Aug 2026
Trident Texofab Ltd
Pursuant to Regulation 30 read with Schedule III Part A Para A and Regulation 47 of SEBI Listing Regulations, we hereby enclose copies of newspaper advertisement published on 12th August, ....
Trident Texofab Ltd has published a newspaper advertisement regarding the extract of the Un-Audited Standalone Financial Results for the quarter ended June 30,2026. The results are available on the company's website.
BSECompany UpdateAuditor Change10 Aug 2026
Trident Texofab Ltd
The Board took on record Resignation of M/s. Shah Kailash and Associates LLP, Chartered Accountant, FRN: 109647W as Statutory Auditor of the Company with effect from 10th August, 2026
Trident Texofab Ltd has announced the resignation of its statutory auditor, M/s. Shah Kailash and Associates LLP, effective August 10, 2026. The company has also announced the appointment of M/s. Priti Agrawal & Co. as its internal auditor for the financial year 2026-27. Additionally, the company has released unaudited financial results for the quarter ended June 30, 2026.
BSECompany UpdateResults10 Aug 2026
Trident Texofab Ltd
The Board of Directors inter-alia has approved the Appointment of M/s. Prit Agrawal & CO., Chartered Accountant having FRN No. 152249W as an Internal Auditor for the financial year 2026-27.
Trident Texofab Ltd has announced the appointment of M/s. Prit Agrawal & Co. as an internal auditor for the financial year 2026-27. The company has also disclosed unaudited financial results for the quarter ended June 30, 2026, along with a limited review report by the statutory auditor. The results show a profit of Rs. 52.18 crore for the quarter, with a net profit of Rs. 70.16 crore for the period.
BSEResult▼ NegativeResults10 Aug 2026
Trident Texofab Ltd
Un-Audited Financial Results for the quarter ended on June 30, 2026 along with Limited Review Report on said results by the Statutory Auditor of the Company
Trident Texofab Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at ₹2,614.26 crore, a decline of 22.3% from ₹3,357.02 crore in the same quarter last year. The company has also reported a net loss of ₹200.94 crore for the quarter, compared to a net profit of ₹101.59 crore in the same quarter last year.
BSEBoard Meeting▼ NegativeResults10 Aug 2026
Trident Texofab Ltd
Outcome of Board Meeting held on 10.08.2026
Trident Texofab Ltd announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at ₹2,614.26 crore, a decrease of 21.5% from ₹3,357.02 crore in the same quarter last year. The company reported a net loss of ₹200.94 crore, compared to a net profit of ₹101.59 crore in the same quarter last year. The board of directors approved the appointment of M/s. Priti Agrawal & Co. as the internal auditor for the financial year 2026-27.